Affinage · Plasmodium

ARPS10

PF3D7_1460900 · ribosomal protein S10, apicoplast, putative

Annotated
2026-09-08
13 papers in source corpus 3 papers cited in narrative 3 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ARPS10 (PF3D7_1460900) is annotated as an apicoplast ribosomal protein S10, but the available corpus characterizes it not through any biochemical or ribosomal function but as a genetic modifier of artemisinin susceptibility in Plasmodium falciparum. A nonsynonymous polymorphism in ARPS10 shows strong genome-wide association with artemisinin resistance across Southeast Asia and marks a permissive genetic background on which kelch13 resistance mutations preferentially arise (PMID:25599401). This modifier role is causally demonstrated: introducing the ARPS10-V127M variant into a kelch13-C580Y parasite, but not into a wild-type kelch13 parasite, increases ring-stage survival in the RSA0–3h assay, establishing that ARPS10-V127M acts epistatically with the kelch13 resistance allele rather than conferring resistance on its own (PMID:36303209). The resistance-associated ARPS10 locus also carries a blood-stage fitness cost, as alleles inherited from an artemisinin-resistant parent are strongly selected against over successive asexual cycles in experimental crosses (PMID:31609965). Beyond this population-genetic and epistatic role, no direct biochemical, structural, or ribosome-associated function of the ARPS10 protein has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 3 steps
  1. 2015 Medium

    Before this work it was unknown what genetic features distinguished parasites prone to acquiring artemisinin resistance; associating an ARPS10 polymorphism with resistance established it as a marker of a predisposing genetic background.

    Evidence Genome-wide association study across 15 Southeast Asian sites with population structure analysis in P. falciparum

    PMID:25599401

    Open questions at the time
    • Association only; no causal or biochemical test of the ARPS10 variant
    • Does not establish whether ARPS10 affects the ribosome or a separate pathway
    • Does not distinguish ARPS10 causation from linkage to other chromosome 14 loci
  2. 2019 Medium

    It was unknown whether resistance-associated ARPS10 alleles carry a fitness penalty; experimental crosses showed strong selection against the resistant-parent allele at this locus across asexual cycles, revealing a blood-stage fitness cost.

    Evidence Experimental genetic crosses in humanized mice with selective whole-genome amplification and pooled allele-frequency tracking in P. falciparum

    PMID:31609965

    Open questions at the time
    • Selection was measured at the locus, not attributed to the ARPS10 coding variant specifically
    • Mechanism of the fitness cost was not defined
    • No biochemical characterization of ARPS10 protein
  3. 2022 High

    The GWAS association left open whether ARPS10-V127M is causally involved; allelic replacement showed it increases ring survival only in a kelch13-C580Y background, establishing it as an epistatic modifier rather than an independent resistance determinant.

    Evidence Allelic replacement mutagenesis in P. falciparum 3D7 combined with RSA0–3h ring survival assay and epistasis analysis

    PMID:36303209

    Open questions at the time
    • The variant was introduced together with FD-D193Y, leaving the independent contribution of ARPS10-V127M alone undefined
    • The molecular mechanism by which the variant modifies kelch13-mediated survival is unknown
    • Single-lab result

Open questions

Synthesis pass · forward-looking unresolved questions
  • The biochemical function of the ARPS10 protein and the mechanism linking its variant to artemisinin susceptibility remain unresolved.
  • No experimental confirmation of apicoplast ribosome association for the ARPS10 protein in the corpus
  • No mechanistic connection between ARPS10-V127M and kelch13 pathway function
  • Independent effect of ARPS10-V127M separate from co-introduced variants not established

Mechanism profile

Synthesis pass · controlled-vocabulary classification

Evidence

Reading pass · 3 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2015 A nonsynonymous polymorphism in ARPS10 (PF3D7_1460900) showed strong genome-wide association with artemisinin resistance in a large multicenter study across Southeast Asia, and was identified as a marker of a genetic background on which kelch13 mutations are particularly likely to arise, indicating ARPS10 variants predispose parasites to acquiring artemisinin resistance-causing mutations. Genome-wide association study (GWAS) across 15 Southeast Asian locations with fine population structure analysis Nature genetics Medium 25599401
2022 Introducing the ARPS10-V127M variant (together with FD-D193Y) into a kelch13-C580Y-containing P. falciparum 3D7 parasite, but not into wild-type kelch13 parasites, significantly increased parasite survival in the 0–3 h ring survival assay (RSA0–3h), demonstrating that ARPS10-V127M is a modifier of artemisinin susceptibility that acts epistatically with the kelch13-C580Y allele. Transgenic parasite generation by allelic replacement mutagenesis; ring survival assay (RSA0–3h); genetic epistasis analysis Malaria journal High 36303209
2019 Strong selection against alleles from an artemisinin-resistant parent at the chromosome 14 locus containing ARPS10 was observed across multiple asexual blood stage cycles in experimental genetic crosses (selection coefficient s ≤ 0.18/asexual cycle), indicating that the ARPS10 locus harbors alleles that incur a fitness cost in blood stage parasites when inherited from the resistant parent. Experimental genetic crosses using humanized mice; selective whole genome amplification and pooled sequencing to track allele frequencies across lifecycle stages PLoS genetics Medium 31609965

Source papers

Stage 0 corpus · 13 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2015 Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nature genetics 471 25599401
2019 Genetic mapping of fitness determinants across the malaria parasite Plasmodium falciparum life cycle. PLoS genetics 43 31609965
2019 A comprehensive analysis of drug resistance molecular markers and Plasmodium falciparum genetic diversity in two malaria endemic sites in Mali. Malaria journal 30 31718631
2017 Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda. Malaria journal 28 28068997
2020 Antimalarial drug resistance molecular makers of Plasmodium falciparum isolates from Sudan during 2015-2017. PloS one 26 32817665
2017 Clinical and molecular surveillance of artemisinin resistant falciparum malaria in Myanmar (2009-2013). Malaria journal 25 28806957
2017 Molecular surveillance of artemisinin resistance falciparum malaria among migrant goldmine workers in Myanmar. Malaria journal 15 28249583
2020 Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan. Malaria journal 13 32070355
2022 Prevalence of arps10, fd, pfmdr-2, pfcrt and pfkelch13 gene mutations in Plasmodium falciparum parasite population in Uganda. PloS one 11 35511795
2019 Plasmodium berghei sporozoite specific genes- PbS10 and PbS23/SSP3 are required for the development of exo-erythrocytic forms. Molecular and biochemical parasitology 9 31251952
2022 Apicoplast ribosomal protein S10-V127M enhances artemisinin resistance of a Kelch13 transgenic Plasmodium falciparum. Malaria journal 7 36303209
2024 Putative molecular markers of Plasmodium falciparum resistance to antimalarial drugs in malaria parasites from Ghana. Frontiers in epidemiology 4 38456076
2025 A Novel Plasmodium falciparum Kelch13 A675T Mutation and High Levels of Chloroquine and Sulfadoxine-Pyrimethamine Resistance in Burundi. medRxiv : the preprint server for health sciences 1 40666336